The dealmaker now redefining commercialization

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dominic (Nick) Marasco, Executive President and Chief Commercial Officer at Envision Pharma Group.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Nick, covering:

• Building businesses, learning lots, and selling BioAgilytix
• With many options on the table... what was it that attracted him to Envision Pharma Group
• The real-life benefits and tangible impact of AI for pharma and biopharma companies
• Why great science and outstanding services that help will continuously be funded, irrespective of the ebbs and flows of the market

Dominic (Nick) Marasco is an entrepreneurial executive. He has over 25 years of executive experience in C-suite strategic planning, commercial operations, global business development, clinical Phase III trial design strategy, alliance management, financial resourcing, and P&L oversight within the Pharmaceutical, Biotech, and Medical Device industries.

Before joining Envision Pharma Group as Executive President and Chief Commercial Officer, Dominic served as Chief Commercial Officer of BioAgilytix, and in his tenure, he was actively involved in two buyer-side acquisitions and three integrations, as well as a seller-side sale of the company to new private equity owners, all within a 24-month timeframe. Before BioAgilytix, he served as Executive Vice President of Global Business Development and Commercial at Syneos Health, where he led the overall strategic direction of the worldwide business development team for the commercial division both in the U.S. and internationally.

He was previously Head of U.S. Sales for the Neuroscience Business Unit at Amgen, Inc., and before that, Global Commercial Head of Amgen Biosimilars. Dominic has also held commercial positions at Sandoz Biopharmaceuticals (a Novartis company).

He received his Bachelor of Science in Pharmacy from the Philadelphia College of Pharmacy and Science and ais an alum of the Harvard Business School Advanced Management Program. Dominic resides in Nevada.

Connect on LinkedIn: here

----

Please subscribe, tell your industry colleagues, and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital, and content agency helping companies differentiate, get noticed, and grow in life sciences.